Product Information
LOJAIMIESS 0.1-0.02-0.01 TAB is a generic product labeled by Xiromed LLC, priced at $0.2436 per EA under NDC 70700020793. Its NADAC has been published 39 times since Oct 1, 2025.
LOJAIMIESS 0.1-0.02-0.01 TAB
Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tabletsManufacturer
Xiromed LLCNDC
70700020793
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200493On Market Since
1/29/2025
Price Statistics
The NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has been published 39 times since Oct 1, 2025, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2436 per EA |
|---|---|
| All-time high | $0.2436 (Jun 24, 2026) |
| All-time low | $0.1911 (Dec 17, 2025) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.2137 |
| Average price | $0.2158 |
| Largest weekly change | -7.0% (Nov 19, 2025) |
| Weeks tracked | 39 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LOJAIMIESS 0.1-0.02-0.01 TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOJAIMIESS 0.1-0.02-0.01 TAB, manufactured by Xiromed LLC, is $0.2436 per EA (NDC 70700020793), effective Jun 24, 2026.
How has the price of LOJAIMIESS 0.1-0.02-0.01 TAB changed over time?
Over the history we have for it, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has risen 13.4%. It has been tracked across 39 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for LOJAIMIESS 0.1-0.02-0.01 TAB?
Since Oct 1, 2025, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has ranged from a low of $0.1911 (Dec 17, 2025) to a high of $0.2436 (Jun 24, 2026), with a median of $0.2137 per EA.
Are there cheaper alternatives to LOJAIMIESS 0.1-0.02-0.01 TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOJAIMIESS 0.1-0.02-0.01 TAB, so no direct lower-cost alternative is listed.
Who manufactures LOJAIMIESS 0.1-0.02-0.01 TAB?
LOJAIMIESS 0.1-0.02-0.01 TAB (NDC 70700020793) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification